World Health Organization Recommends University of Oxford’s Malaria Vaccine for Children

(IN BRIEF) The University of Oxford’s R21/Matrix-M™ malaria vaccine, developed in collaboration with the Serum Institute of India and leveraging Novavax’s adjuvant technology, has received a recommendation for use by the World Health Organization (WHO). After rigorous scientific review by … Read the full press release →